A novel multi-ingredient supplement significantly improves ocular symptom severity and tear production in patients with dry eye disease: results from a randomized, placebo-controlled clinical trial.

Gioia N, Gerson J, Ryan R, Barbour K, Poteet J, Jennings B, Sharp M, Lowery R, Wilson J, Morde A, Rai D, Padigaru M, Periman LM

Open source

DOI
10.3389/fopht.2024.1362113
Published
2024
Container
Frontiers in ophthalmology
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fopht.2024.1362113,
  title = {A novel multi-ingredient supplement significantly improves ocular symptom severity and tear production in patients with dry eye disease: results from a randomized, placebo-controlled clinical trial.},
  author = {Gioia N and Gerson J and Ryan R and Barbour K and Poteet J and Jennings B and Sharp M and Lowery R and Wilson J and Morde A and Rai D and Padigaru M and Periman LM},
  year = {2024},
  journal = {Frontiers in ophthalmology},
  doi = {10.3389/fopht.2024.1362113},
  url = {https://doi.org/10.3389/fopht.2024.1362113}
}

RIS

TY  - JOUR
TI  - A novel multi-ingredient supplement significantly improves ocular symptom severity and tear production in patients with dry eye disease: results from a randomized, placebo-controlled clinical trial.
AU  - Gioia N
AU  - Gerson J
AU  - Ryan R
AU  - Barbour K
AU  - Poteet J
AU  - Jennings B
AU  - Sharp M
AU  - Lowery R
AU  - Wilson J
AU  - Morde A
AU  - Rai D
AU  - Padigaru M
AU  - Periman LM
PY  - 2024
JO  - Frontiers in ophthalmology
DO  - 10.3389/fopht.2024.1362113
UR  - https://doi.org/10.3389/fopht.2024.1362113
ER  - 

APA

N, G., J, G., R, R., K, B., J, P., B, J., M, S., R, L., J, W., A, M., D, R., M, P., & LM, P. (2024). A novel multi-ingredient supplement significantly improves ocular symptom severity and tear production in patients with dry eye disease: results from a randomized, placebo-controlled clinical trial.. Frontiers in ophthalmology. https://doi.org/10.3389/fopht.2024.1362113

Source records